5% stake reports

Filings through 10/02

Anyone who comes to hold more than 5% of a US-listed company must report it. A 13D holder may seek a say in the company; a 13G holder is a passive investor.

5% stake reports: 652; Last 30 days · 09/03–10/02
13D reports: 357; Last 30 days · 09/03–10/02
First reports over 5%: 241; Last 30 days · 09/03–10/02
Dropped below 5%: 83; Last 30 days · 09/03–10/02

5% stake reports

Nano Dimension NNDM

	Holder			Kind
08/21	Tang Capital Management08/21	9.1%19,232,538 sh	+1.2pp	13G passive
07/27	Tang Capital Management07/27	7.9%16,715,812 sh	+1.1pp	13DAmendment
07/22	Oramed Pharmaceuticals07/22	3.3%6,879,708 sh	−3.9pp	13DAmendment
07/20	Murchinson07/20	8.1%17,136,276 sh	−1.5pp	13DAmendment
06/30	Tang Capital Management06/30	6.8%14,292,813 sh	First report	13D
06/23	Murchinson06/23	9.6%20,285,450 sh	+2.2pp	13DAmendment
06/17	Oramed Pharmaceuticals06/17	7.2%15,079,708 sh	+2.0pp	13DAmendment
05/21	Murchinson05/21	7.4%15,550,000 sh	No earlier report	13DAmendment
02/19	Oramed Pharmaceuticals02/19	5.2%10,942,087 sh	+0.2pp	13DAmendment
01/29	Oramed Pharmaceuticals01/29	5%10,549,430 sh	First report	13D
25/07/14	Anson Funds Management25/07/14	4.2%9,057,952 sh	−3.3pp	13DAmendment
25/07/03	Anson Funds Management25/07/03	7.5%16,361,433 sh	No earlier report	13DAmendment